Introduction: Challenges to finding a cure for HIV infection

Current Opinion in HIV and AIDS

Volumn 6, Issue 1, 2011, Pages 1-3

  Richman, Douglas D ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Stein Clinical Sciences Building ^*  (United States)

Author keywords

Antiretroviral therapy; HIV; HIV cure; Latency; Viral reservoirs

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS LATENCY; VIRUS REPLICATION; PATHOGENICITY; REVIEW; VIROLOGY;

ANTI-HIV AGENTS; HIV; HIV INFECTIONS; HUMANS; VIRUS LATENCY;

EID: 79954442770     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e328340ffa6     Document Type: Article

References (12)

1. Chun T-W, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-188. (Pubitemid 27209433)
2. Richman DD, Margolis DM, Delaney M, et al. The challenge of finding a cure for HIV infection. Science 2009; 23:1304-1307.
3. Hermankova M, Ray SC, Ruff C, et al. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy. JAMA 2001; 286:196-207. (Pubitemid 32640851)
4. Persaud D, Siberry GK, Ahonkhai A, et al. Continued production of drugsensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads. J Virol 2004; 78:968-979. (Pubitemid 38067618)
5. Kieffer TL, Finucane MM, Nettles RE, et al. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J Infect Dis 2004; 189:1452-1465. (Pubitemid 38543595)
6. Han Y, Wind-Rotolo HY, Yang HC, et al. Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007; 5:95-106. (Pubitemid 46151868)
7. Carter CC, Nuga-Onafuwa A, McNamara LA, et al. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010; 446-551.
8. Tobin NH, Learn GH, Holte SE, et al. Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus. J Virol 2005; 79:9625-9634. (Pubitemid 41022306)
9. + T cells. J Virol 2006; 80:441-457.
10. Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 2006; 12:1316-1322. (Pubitemid 44706935)
11. + T cells in the simian immunodeficiency virus/macaque model of human immunodeficiency virus type 1 latency. J Virol 2003; 77:4938-4949. (Pubitemid 36402842)
12. Laszlo J, The cure of childhood leukemia: into the age of miracles. New Brunswick, NJ: Rutgers University Press; 1995. pp 287.